Literature DB >> 20808096

Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression.

Ahmad Khundakar1, Christopher Morris, Arthur Oakley, Alan J Thomas.   

Abstract

OBJECTIVE: To assess glial and neuronal density and neuronal volume in two areas of the caudate nucleus in late-life major depression.
DESIGN: A postmortem study using the disector and nucleator methods to estimate neuronal density and volume and glial density of cells from human brain tissue from the anterior portion (dorsolateral and ventromedial aspects) of the caudate nucleus.
SETTING: Brain tissues were obtained from the Newcastle Brain Tissue Resource at Newcastle University, UK. PARTICIPANTS: The study group consisted of 13 subjects with late-life major depression and nine comparison subjects of similar age.
RESULTS: Evidence of moderate reductions in neuronal density was found in the depressed group in both the dorsolateral and ventromedial areas of the caudate nucleus. There were no significant changes in glial density or neuronal volume in either area nor was there any evidence of differences in depression in early and late-onset subgroups.
CONCLUSIONS: Neuroimaging abnormalities in frontal and subcortical areas including ischemic hyperintensities and a reduction in volume and metabolism in the caudate nucleus have been reported in late-life depression, and previous morphometric studies have reported neuronal changes in prefrontal cortical areas. The findings in this study extend these morphometric investigations in late-life depression to the caudate nucleus, suggesting that neuronal abnormalities are present in this subcortical nucleus as well as in these related prefrontal areas.

Entities:  

Mesh:

Year:  2011        PMID: 20808096     DOI: 10.1097/JGP.0b013e3181df4642

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  13 in total

1.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

2.  Assessment of neuroplasticity in late-life depression with transcranial magnetic stimulation.

Authors:  Apoorva Bhandari; Jennifer I Lissemore; Tarek K Rajji; Benoit H Mulsant; Robin F H Cash; Yoshihiro Noda; Reza Zomorrodi; Jordan F Karp; Eric J Lenze; Charles F Reynolds; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J Psychiatr Res       Date:  2018-08-31       Impact factor: 4.791

3.  Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.

Authors:  Filip Bouckaert; François-Laurent De Winter; Louise Emsell; Annemieke Dols; Didi Rhebergen; Martien Wampers; Stefan Sunaert; Max Stek; Pascal Sienaert; Mathieu Vandenbulcke
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

4.  Increased glia density in the caudate nucleus in williams syndrome: Implications for frontostriatal dysfunction in autism.

Authors:  Kari L Hanson; Caroline H Lew; Branka Hrvoj-Mihic; Kimberly M Groeniger; Eric Halgren; Ursula Bellugi; Katerina Semendeferi
Journal:  Dev Neurobiol       Date:  2017-11-13       Impact factor: 3.964

5.  The vascular depression hypothesis: an update.

Authors:  Joel R Sneed; Michelle E Culang-Reinlieb
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

6.  Subcortical biophysical abnormalities in patients with mood disorders.

Authors:  A Kumar; S Yang; O Ajilore; M Wu; R Charlton; M Lamar
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

Review 7.  Involvement of brain-derived neurotrophic factor in late-life depression.

Authors:  Yogesh Dwivedi
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-19       Impact factor: 4.105

8.  Neurochemical characterization of the tree shrew dorsal striatum.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Front Neuroanat       Date:  2011-08-17       Impact factor: 3.856

9.  Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option?

Authors:  Mauro Giovanni Carta; Andrea Norcini Pala; Gabriele Finco; Mario Musu; Maria Francesca Moro
Journal:  Clin Pract Epidemiol Ment Health       Date:  2015-02-27

10.  Meta-analysis of molecular imaging of serotonin transporters in major depression.

Authors:  Gregor Gryglewski; Rupert Lanzenberger; Georg S Kranz; Paul Cumming
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.